Literature DB >> 2024471

Glycosylation and oligomerization of the spike protein of Marburg virus.

H Feldmann1, C Will, M Schikore, W Slenczka, H D Klenk.   

Abstract

The oligosaccharide side chains of the glycoprotein of Marburg virus (MW 170,000) have been analyzed by determining their sensitivity to enzymatic degradation and their reactivity with lectins. It was found that they consist of N- and O-glycans. Studies employing chemical cross-linking showed that the glycoprotein is present as a homotrimer in the viral envelope.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2024471      PMCID： PMC7172319          DOI： 10.1016/0042-6822(91)90680-a

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  16 in total

1.  Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus.

Authors:  R A Olmsted; B R Murphy; L A Lawrence; N Elango; B Moss; P L Collins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Identification and analysis of Ebola virus messenger RNA.

Authors:  A Sanchez; M P Kiley
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

3.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

4.  Unusual lectin-binding properties of a herpes simplex virus type 1-specific glycoprotein.

Authors:  S Olofsson; S Jeansson; E Lycke
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

5.  Descriptive analysis of Ebola virus proteins.

Authors:  L H Elliott; M P Kiley; J B McCormick
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

6.  Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules.

Authors:  H Shida; S Dales
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

7.  Cross-linking studies show that herpes simplex virus type 1 glycoprotein C molecules are clustered in the membrane of infected cells.

Authors:  G E Kikuchi; J C Glorioso; R Nairn
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

8.  Respiratory syncytial virus polypeptides. IV. The oligosaccharides of the glycoproteins.

Authors:  C Gruber; S Levine
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

9.  O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus.

Authors:  D C Johnson; P G Spear
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

10.  Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein.

Authors:  K V Holmes; E W Doller; L S Sturman
Journal:  Virology       Date:  1981-12       Impact factor: 3.616
View more
  43 in total

1.  Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells.

Authors:  C Sänger; E Mühlberger; E Ryabchikova; L Kolesnikova; H D Klenk; S Becker
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions.

Authors:  L Kolesnikova; E Mühlberger; E Ryabchikova; S Becker
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Authors:  S Watanabe; A Takada; T Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment.

Authors:  Larissa Kolesnikova; Harald Bugany; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.

Authors:  Philipp A Ilinykh; Kai Huang; Rodrigo I Santos; Pavlo Gilchuk; Bronwyn M Gunn; Marcus M Karim; Jenny Liang; Mallorie E Fouch; Edgar Davidson; Diptiben V Parekh; James B Kimble; Colette A Pietzsch; Michelle Meyer; Natalia A Kuzmina; Larry Zeitlin; Erica Ollmann Saphire; Galit Alter; James E Crowe; Alexander Bukreyev
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

6.  VP24 of Marburg virus influences formation of infectious particles.

Authors:  Sandra Bamberg; Larissa Kolesnikova; Peggy Möller; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope.

Authors:  Eva Mittler; Larissa Kolesnikova; Thomas Strecker; Wolfgang Garten; Stephan Becker
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

9.  Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.

Authors:  Waranyoo Phoolcharoen; Seong H Bhoo; Huafang Lai; Julian Ma; Charles J Arntzen; Qiang Chen; Hugh S Mason
Journal:  Plant Biotechnol J       Date:  2011-02-01       Impact factor: 9.803

10.  Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.

Authors:  Masahiro Kajihara; Andrea Marzi; Eri Nakayama; Takeshi Noda; Makoto Kuroda; Rashid Manzoor; Keita Matsuno; Heinz Feldmann; Reiko Yoshida; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.